May 8, 2020 / 1:10 AM / 21 days ago

BRIEF-Cynata Therapeutics Gets Ethics Approval To Commence Clinical Trial In Covid-19

May 8 (Reuters) - Cynata Therapeutics Ltd:

* RECEIVES ETHICS APPROVAL TO COMMENCE CLINICAL TRIAL IN COVID-19 AND CLINICAL DEVELOPMENT UPDATE

* APPROVAL FOR CLINICAL TRIAL TO TEST EFFICACY OF CYMERUS MESENCHYMAL STEM CELLS IN ADULTS ADMITTED TO INTENSIVE CARE WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below